Device Orthodontics

Pitts21 Pro

Payments companies reported to CMS as associated with Pitts21 Pro. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$3.5Massociated payments (2023-2025)
822clinicians with associated payments
1company reporting

By year

2023 $1.3M
2024 $140K
2025 $2.0M

Payments reported as associated with Pitts21 Pro, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthodontics and Dentofacial Orthopedics $3.4M
Dentist $36K
General Practice (Dentist) $11K
Pediatric Dentistry $1,173
Dermatology $706
Family Medicine $554

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Pitts21 Pro

These are the largest totals companies reported as associated with Pitts21 Pro. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Thomas Pitts Reno, NV Orthodontics and Dentofacial Orthopedics $2,989,809.04
Leah Walker Carlsbad, CA Orthodontics and Dentofacial Orthopedics $10,438.00
Tarek Abousheta Irvine, CA General Practice (Dentist) $7,343.84
Brett Mooso Idaho Falls, ID Orthodontics and Dentofacial Orthopedics $7,277.36
Jeffrey Haskins Centennial, CO Orthodontics and Dentofacial Orthopedics $6,523.16
John Griffiths Las Vegas, NV Orthodontics and Dentofacial Orthopedics $6,329.20
Douglas Baum Roseville, CA Orthodontics and Dentofacial Orthopedics $5,578.68
Ronald Chung San Francisco, CA Orthodontics and Dentofacial Orthopedics $5,510.30
Rich Hardie Escondido, CA Orthodontics and Dentofacial Orthopedics $5,442.30
Chuck Carlson Los Angeles, CA Orthodontics and Dentofacial Orthopedics $5,284.66

Prescribed Pitts21 Pro?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.